Parkinson's disease treatment cost in Germany is determined by the diagnostic complexity and selected therapy, with a brain MRI with contrast ranging from $900 to $1,000. Primary surgical interventions like Deep brain stimulation (DBS) surgery cost between $50,000 and $80,000, while prices depend on disease stage and clinic specialization. Patients can expect 20-40% savings compared to the US, with top care centered in Hamburg, Frankfurt am Main, and Berlin.
Typical Parkinson's Disease Treatment Costs in Germany
Bookimed Expert Insight: Advanced stage patients requiring surgical intervention should prioritize centers with high-volume neurology departments. Asklepios Hospital Barmbek is a top choice. It is ranked No.1 for international patients by the Medical Travel Quality Alliance (MTQA). For those seeking research-driven care, Charité - Universitätsmedizin Berlin offers AI-supported diagnostics. Patients interested in regenerative approaches may consider Medical Center in Solingen. Professor Marcel Dihne there provides expertise in stem cell research. Always verify if the clinic provides specific reception services for foreign nationals.
| Germany | Turkey | Austria | |
| Medication treatment for Parkinson's disease | from $4,500 | from $1,000 | from $2,000 |
| Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) | from $22,000 | from $10,000 | from $16,000 |
| Deep brain stimulation (DBS) surgery | from $50,000 | from $23,000 | from $45,000 |
| Stem cell therapy for Parkinson's disease | from $30,000 | from $25,000 | from $35,000 |
Prof. Dr. Urban is listed among Germany's best neurologists by Focus magazine for his expertise in Parkinson's disease. He heads the Neurology Department at Asklepios Klinik Barmbek.
Professor Dihné is a true master in understanding the subtle mechanisms of the nervous system, specializing in Parkinson's disease at the Academic Hospital Solingen.
Director of the Clinic for Neurology with Experimental Neurology, Center Leader CC15>
Prof. Uta Meyding-Lamade is a leading neurologist in Germany specializing in stroke, multiple sclerosis, rheumatologic diseases and neurological disorders treatment. She holds several positions such as head of Neurology Department in Nordwest Clinic and regional adviser for stroke treatment at Robert Koch Institute, and has received numerous scholarships and prizes for her work.
Written by Kateryna Zamkovska